Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Janel A, Dubois-Galopin F, Bourgne C, Berger J, Tarte K, Boiret-Dupré N, Boisgard S, Verrelle P, Déchelotte P, Tournilhac O, Berger MG.

Stem Cells Dev. 2014 Dec 15;23(24):2972-82. doi: 10.1089/scd.2014.0229.

PMID:
25055118
2.

Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Pontikoglou C, Kastrinaki MC, Klaus M, Kalpadakis C, Katonis P, Alpantaki K, Pangalis GA, Papadaki HA.

Stem Cells Dev. 2013 May 1;22(9):1329-41. doi: 10.1089/scd.2012.0255. Epub 2013 Feb 1.

4.

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.

Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, Hartmann TN.

PLoS One. 2011;6(8):e23758. doi: 10.1371/journal.pone.0023758. Epub 2011 Aug 18.

5.

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.

Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B.

Haematologica. 2017 Sep;102(9):1594-1604. doi: 10.3324/haematol.2016.163337. Epub 2017 Jun 8.

6.

Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment.

Carrancio S, Blanco B, Romo C, Muntion S, Lopez-Holgado N, Blanco JF, Briñon JG, San Miguel JF, Sanchez-Guijo FM, del Cañizo MC.

PLoS One. 2011;6(10):e26241. doi: 10.1371/journal.pone.0026241. Epub 2011 Oct 20.

7.

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.

Haematologica. 2002 May;87(5):490-9.

8.

Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.

Fecteau JF, Messmer D, Zhang S, Cui B, Chen L, Kipps TJ.

Blood. 2013 Feb 7;121(6):971-4. doi: 10.1182/blood-2012-08-447813. Epub 2012 Dec 18.

9.

Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.

Sampalo A, Navas G, Medina F, Segundo C, Cámara C, Brieva JA.

Blood. 2000 Nov 1;96(9):3168-74.

PMID:
11049999
10.

Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.

Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC.

Haematologica. 2006 Aug;91(8):1017-26. Epub 2006 Jul 25.

11.

Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders.

Campioni D, Bardi MA, Cavazzini F, Tammiso E, Pezzolo E, Pregnolato E, Volta E, Cuneo A, Lanza F.

Ann Hematol. 2012 Oct;91(10):1563-77. doi: 10.1007/s00277-012-1500-8. Epub 2012 Jun 14.

PMID:
22696050
12.

Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.

Abdul-Aziz AM, Sun Y, Hellmich C, Marlein CR, Mistry J, Forde E, Piddock RE, Shafat MS, Morfakis A, Mehta T, Di Palma F, Macaulay I, Ingham CJ, Haestier A, Collins A, Campisi J, Bowles KM, Rushworth SA.

Blood. 2019 Jan 31;133(5):446-456. doi: 10.1182/blood-2018-04-845420. Epub 2018 Nov 6.

PMID:
30401703
13.

Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.

Gu Z, Cao X, Jiang J, Li L, Da Z, Liu H, Cheng C.

Cell Signal. 2012 Dec;24(12):2307-14. doi: 10.1016/j.cellsig.2012.07.012. Epub 2012 Jul 20.

PMID:
22820504
14.

Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.

Balakrishnan K, Burger JA, Quiroga MP, Henneberg M, Ayres ML, Wierda WG, Gandhi V.

Blood. 2010 Aug 19;116(7):1083-91. doi: 10.1182/blood-2009-10-246199. Epub 2010 May 4.

15.

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Ding W, Nowakowski GS, Knox TR, Boysen JC, Maas ML, Schwager SM, Wu W, Wellik LE, Dietz AB, Ghosh AK, Secreto CR, Medina KL, Shanafelt TD, Zent CS, Call TG, Kay NE.

Br J Haematol. 2009 Nov;147(4):471-83. doi: 10.1111/j.1365-2141.2009.07868.x. Epub 2009 Sep 8.

16.

Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B-CLL: implications for rituximab resistance in CLL.

Marquez ME, Hernández-Uzcátegui O, Cornejo A, Vargas P, Da Costa O.

Br J Haematol. 2015 Apr;169(2):211-8. doi: 10.1111/bjh.13286. Epub 2015 Jan 22.

PMID:
25612644
17.

Differential expression of alpha-smooth muscle actin molecule in a subset of bone marrow stromal cells, in b-cell chronic lymphocytic leukemia, autoimmune disorders and normal fetuses.

Papadopoulos N, Simopoulos C, Kotini A, Lambropoulou M, Tolparidou I, Tamiolakis D.

Eur J Gynaecol Oncol. 2001;22(6):447-50.

PMID:
11874079
18.

Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S.

PLoS One. 2013;8(1):e55319. doi: 10.1371/journal.pone.0055319. Epub 2013 Jan 29.

19.

Adult cardiac-resident MSC-like stem cells with a proepicardial origin.

Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ, Rashidianfar A, Biben C, Zoellner H, Colvin EK, Pimanda JE, Biankin AV, Zhou B, Pu WT, Prall OW, Harvey RP.

Cell Stem Cell. 2011 Dec 2;9(6):527-40. doi: 10.1016/j.stem.2011.10.002.

20.

Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.

Desbourdes L, Javary J, Charbonnier T, Ishac N, Bourgeais J, Iltis A, Chomel JC, Turhan A, Guilloton F, Tarte K, Demattei MV, Ducrocq E, Rouleux-Bonnin F, Gyan E, Hérault O, Domenech J.

Stem Cells Dev. 2017 May 15;26(10):709-722. doi: 10.1089/scd.2016.0295. Epub 2017 Apr 10.

Supplemental Content

Support Center